Foundayo (Orforglipron) Tablets | Weight Management | Sorted Wellness
Purchase Options
Purchase Options
Purchase Options
Purchase Options
Purchase Options
Purchase Options
Active ingredient
Orforglipron.
Formulation and available strengths
Oral GLP-1 receptor agonist tablets. Available listings: 0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg (30 tablets per variant).
Licensed dosage guidance
The authorised adult titration starts at 0.8 mg once daily, followed by 2.5, 5.5, 9, 14.5 and 17.2 mg, with at least one month at each step. Do not move to the next strength unless instructed by the prescriber.
How it is taken
Swallow by mouth once daily; the MHRA states there are no food or water timing restrictions.
Clinical guidance: The dose sequence below is general information from the UK-approved product information, not an individual prescription. Do not start, change or restart a medicine without assessment and specific instructions from the prescriber.
Safety: Discuss your medical history, pregnancy or breastfeeding, previous pancreatitis or gallbladder problems, allergies, kidney problems and all current medicines with your clinician. Side effects and contraindications vary by product; consult the supplied patient information leaflet.
Other ingredients: Inactive ingredients and excipients may vary by strength, formulation and manufacturer. The exact dispensed pack's patient information leaflet is the authoritative list and should be checked for allergies or intolerances.
Supply: Subject to clinical assessment, prescription where required, and pharmacy approval. Product availability and the dispensed pack must be confirmed by Faces Pharmacy.
UK product information: Read the reference for detailed precautions, excipients and dosing.